CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +6,408 | 343,275 | ||
| 2026-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +6,408 | 3,422,366 | ||
| 2026-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2026-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2025-12-11 | BAKER BROS. ADVISORS LP Director | Purchase · $0.01 Prefunded Warrants | +190,523 | $17.49 | $3.3M | 2,335,469 |
| 2025-12-11 | BAKER BROS. ADVISORS LP Director | Purchase · $0.01 Prefunded Warrants | +2,095,191 | $17.49 | $36.6M | 25,996,310 |
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +10,565 | 336,867 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +10,565 | 3,415,958 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy)uy) | +31,695 | 31,695 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +31,695 | 31,695 |
Page 1 of 1 · 10 trades